CNBCLean R·
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Read at CNBC →
Business · 1 sources covering this
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/ba9d857b256b0ba933cfde0a8bb87319a5ed4339" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising"></iframe>
